13F

Stock

Adaptimmune Therapeutics Plc

ADAPY · held by 2 managers

Reported value

$9.86K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$17.1K

Price effect on 2 books still in the name

Largest holder

$9.86K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC50.1K$9.86K−$17.1KCut−$17.1K
DANSKE BANK A/S1$0−$1Cut−$1

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.